Benzodiazepine exposure and functional status in older people

Journal of the American Geriatrics Society

Volumn 46, Issue 1, 1998, Pages 71-76

  Ried, L Douglas ^a,b   Johnson, Richard E ^b   Gettman, David A ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

AGED; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DRUG EXPOSURE; FEMALE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; RESPIRATORY TRACT DISEASE;

EID: 0031964198     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01016.x     Document Type: Article

References (42)

1. LaPlante MP. The demographics of disability. Milbank Q 1991;69 (suppl 1-2):55-77.
2. Wenger NK. Cardiovascular disease in the elderly. Ciba Found Symp 1988;134:106-128.
3. Kashyap ML. Cardiovascular disease in the elderly: Current considerations. Am J Cardiol. 1989;63:3-4H.
4. Cannon LA, Marshall JM. Cardiac disease in the elderly population. Clin Geriatr Med 1993;9:499-525.
5. Jette AM, Branch LG, Berlin J. Musculoskeletal impairments and physical disablement among the aged. J Gerontol 1990;45:M203-208.
6. Salive ME, Satterfield S, Ostfeld AM et al. Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults. Public Health Rep 1993;108:314-322.
7. Reidenberg MM. Drug interactions and the elderly. J Am Geriatr Soc 1982;30(suppl 11):S67-68.
8. Moodley P, Golombok S, Lader, M. Effects of clorazepate dipotassium and placebo on psychomotor skills. Percep Mot Skills 1985;61:1121-1122.
9. Hendler N, Cimini C, Terence MA, Long D. A comparison of cognitive impairment due to benzodiazepines and to narcotics. Am J Psychiatry. 1980;137:7:828-830.
10. Scharf MB, Jacoby JA. Lorazepam - Efficacy, side effects, and rebound phenomena. Clin Pharmacol Ther 1982;31:175-179.
11. Miller LG, Jankovic J. Neurolic approach to drug-induced movement disorders: A study of 125 patients. South Med J 1990;83:525-532.
12. Beers M, Avorn J, Soumerai SB et al. Psychoactive medication use in intermediate-care facility residents. JAMA 1988;260:20:3016-3020.
13. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987;107:169-173.
14. Magaziner J, Simonsick EM, Kashner TM et al. Predictors of functional recovery one year following hospital discharge for hip fracture: A prospective study. J Gerontol 1990;45:M101-107.
15. Baum C, Kennedy DL, Forbes MB, Jones JK. Drug use in the United States in 1981. JAMA 1984;251:1293-1297.
16. Mellinger GD, Baiter MB. Prevalence and patterns of use of psychotherapeutic drugs: Results from a 1979 national survey of American adults. In: Tognoni G, Bellantuono C, Lader M, eds. Impact of Psychotropic Drugs. New York: Elsevier, North Holland Biomedical Press, 1981, pp 117-135.
17. Thomson M, Smith WA. Prescribing benzodiazepines for noninstitutionalized elderly (see comments). Can Fam Physician 1995;41:792-798.
18. Swartz M, Landerman R, George LK et al. Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a southern community. Am J Public Health 1991;81:592-596.
19. McNutt LA, Coles FB, McAuliffe T et al. Impact of regulation on benzodiazepine prescribing to a low income elderly population, New York State. J Clin Epidemiol 1994;47:613-625.
20. Stewart RB, Marks RG, Padgett PD, Hale WE. Benzodiazepine use in an ambulatory elderly population: A 14-year overview. Clin Ther 1994;16:118-124.
21. Mayer-Oakes SA, Kelman G, Beers MH et al. Benzodiazepine use in older, community-dwelling southern Californians: Prevalence and clinical correlates. Ann Pharmacother 1993;27:416-421.
22. Ried LD, Johnson RE. Evaluation of the reliability and validity of a measure of anxiolytic drug-use intensity for pharmacoepidemiologic studies. Ann Pharmacother 1992;26:1441-1446.
23. Ried LD, Christensen DB, Stergachis A. Medical and psychosocial factors predictive of psychotropic drug use in elderly patients. Am J Public Health 1990;80:1349-1353.
24. Greenberg JN, Leutz W, Ervin S et al. S/HMO. The Social/Health Maintenance Organization and long-term care. Generations 1985;Summer:51-55.
25. Katz S, Ford AB, Moskowitz RW et al. Studies of illness in the aged; The Index of ADL: A standardized measure of biological and psychological function. JAMA 1963;185:914-919.
26. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and Instrumental Activities of Daily Living. Gerontologist 1969;9:179-186.
27. Spector WD, Katz S, Murphy JB, Fulton JP. The hierarchical relationship between activities of daily living and instrumental activities of daily living. J Chronic Dis 1987;40:481-489.
28. Kempen GIJM, Suurmeijer TPBM. The development of a hierarchical polychotomous ADL-IADL scale for noninstitutionalized elders. Gerontologist 1990;30:497-502.
29. Lichtenstein RL, Thomas JW. Including a measure of health status in Medicare's health maintenance organization capitation formula: Reliability issues. Med Care 1987;25:100-110.
30. Thomas JW, Lichtenstein RL. Functional health measure for adjusting health maintenance organization capitation rates. Health Care Fin Rev 1986;7:85-95.
31. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991;39:1079-1084.
32. Jick H, Walker AM, Watkins RN et al. Oral contraceptives and breast cancer. Am J Epidemiol 1980;112:577-585.
33. Posner JD, Gorman KM, Klein HS, Woldow A. Exercise capacity in the elderly. Am J Cardiol 1986;57:52-58C.
34. Blow FC, Loveland-Cook CA, Booth BM et al. Age-related psychiatric comorbidities and level of functioning in alcoholic veterans seeking outpatient treatment. Hosp Community Psychiatry 1992;43:10:990-995.
35. Wingard DL, Cohn BA, Kaplan GA et al. Sex differentials in morbidity and mortality risks examined by age and cause in the same cohort. Am J Epidemiol 1989;130:601-610.
36. Stewart AL, Greenfield S, Hays RD et al. Functional status and well-being of patients with chronic conditions: Results from the medical outcomes study. JAMA 1989;262:907-913.
37. Manton KG. A longitudinal study of functional change and mortality in the United States. J Gerontol 1988;43:S153-161.
38. Magaziner J, Cadigan DA, Fedder DO, Hebel JR. Medication use and functional decline among community-dwelling older women. J Aging Health 1989;1:470-484.
39. Guralnik JM, Branch LG, Cummings SR, Curb JD. Physical performance measures in aging research. J Gerontol 1989;44:M141-146.
40. Feinstein AR, Josephy BR, Wells CK. Scientific and clinical problems in indexes of functional disability. Ann Intern Med 1986;105:413-420.
41. vanStaa TP, Abenhaim L, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol 1994;47:183-189.
42. Guralnik JM, LaCroix AZ, Everett DF. Comorbidities of chronic conditions and disability among older persons - United States 1984. MMWR Morb Mortal Wkly Rep 1989;38:788-791.